The morbidity associated with radical cytoreductive surgery
is likely underreported.
Furthermore, there is emerging evidence that cytoreductive surgery, the removal of as much of the tumour as possible, may enhance the response to systemic therapy in RCC patients.
For patients with isolated unresectable cardiac metastases from papillary RCC, one reasonable treatment approach is cytoreductive surgery followed by systemic therapy with either sunitinib or temsirolimus.
The main reasons for the increased survival are improvements in cytoreductive surgery
in the 1980s and the use of the taxanes (paclitaxel and docetaxel) in the 1990s.
Now, as with all other cancers who present with metastatic disease, cytoreductive surgery
should not be offered to patients as there is more effective therapy available to them.
Bowne was instrumental in pioneering cytoreductive surgery
and hyperthermic intraperitoneal chemotherapy, otherwise known as HIPEC, at Hahnemann University Hospital in Philadelphia.
Pass combines cytoreductive surgery
, either EPP or pleurectomy, with innovative or standard adjuvant therapies including novel antiangiogenesis inhibitors postoperatively or chemotherapy combinations.
BULLETIN BOARD: BIKO) , has sponsored the first and only long- term Quality of Life study with Wake Forest University Baptist Medical Center involving patients who have survived greater than three years following intraperitoneal hyperthermia (IPH), in conjunction with cytoreductive surgery and chemotherapy.
a surgical oncologist, in a National Cancer Institute supported study on the efficacy of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy.
a professor in the Division of Surgical Oncology at The University of Texas Southwestern Medical Center at Dallas and Chairman of ViaCirQ's Medical Scientific Advisory Board, will present on the use of Intraperitoneal Hyperthermia (IPH) as an adjunctive therapy with cytoreductive surgery and chemotherapy for disseminated peritoneal cancer of gastrointestinal origin at Scripps Memorial Hospital La Jolla Grand Rounds on February 6, 2001.
Five-year data from a study funded by the National Institutes of Health shows patients undergoing intraperitoneal hyperthermia with cytoreductive surgery and chemotherapy live longer and have a better quality of life.
a leading developer and marketer of extracorporeal hyperthermia medical devices, announced that it has commenced a study with Wake Forest University Baptist Medical Center utilizing the ThermoChem-HT(TM) System and related disposables to deliver intraperitoneal hyperthermia (IPH) in combination with cytoreductive surgery
and chemotherapy in the primary treatment of ovarian cancer.